Ropes & Gray Advises Bain Capital Tech Opportunities in its Investment in Axtria
Ropes & Gray advised Bain Capital Tech Opportunities in its $150 million investment in Axtria, a global cloud software and data analytics provider that helps life sciences businesses bring therapeutics to market faster. The transaction was announced on May 13. The press release is here.
Bain Capital Tech Opportunities has deep experience across the life sciences ecosystem, having invested in the growth of Cerevel Therapeutics, Atea Pharmaceuticals and SpringWorks Therapeutics.
The Ropes & Gray team that advised Bain Capital Tech Opportunities was led by private equity partner Elizabeth Gallucci (San Francisco), and included private equity partner Charlie Boer (Boston), litigation & enforcement partners Daniel McCaughey (Boston) and Nicholas Berg (Chicago), life sciences partner Michael Beauvais (Boston) and private equity associate Lucy Corrigan (New York).